39040175|t|Ancestry specific distribution of LPA Kringle IV-Type-2 genetic variants highlight associations to apo(a) copy number, glucose, and hypertension.
39040175|a|Background: High Lp(a) levels contribute to atherosclerotic cardiovascular disease and are tightly regulated by the LPA gene . Lp(a) levels have an inverse correlation with LPA Kringle IV Type-2 (KIV-2) copy number (CN). Black (B) and Hispanic (H) individuals exhibit higher levels of Lp(a), and rates of CVD compared to non-Hispanic Whites (NHW). Therefore, we investigated genetic variations in the LPA KIV-2 region across three ancestries and their associations with metabolic risk factors. Methods: Using published pipelines, we analyzed a multi-ethnic whole exome dataset comprising 3,817 participants from the Washington Heights and Inwood Columbia Aging Project (WHICAP): 886 [NHW (23%), 1,811 Caribbean (C) H (47%), and 1,120 B individuals (29%). Rare and common variants (alternative allele carrier frequency, CF < 0.01 or > 0.99 and 0.01 < CF < 0.99, respectively) were identified and KIV-2 CN estimated. The associations of variants and CN with history of heart disease, hypertension (HTN), stroke, lipid levels and clinical diagnosis of Alzheimer's disease (AD) was assessed. A small pilot provided in-silico validation of study findings. Results: We report 1421 variants in the LPA KIV-2 repeat region, comprising 267 exonic and 1154 intronic variants. 61.4% of the exonic variants have not been previously described. Three novel exonic variants significantly increase the risk of HTN across all ethnic groups: 4785-C/A (frequency = 78%, odds ratio [OR] = 1.45, p = 0.032), 727-T/C (frequency = 96%, OR = 2.11, p = 0.032), and 723-A/G (frequency = 96%, OR = 1.97, p = 0.038). Additionally, six intronic variants showed associations with HTN: 166-G/A, 387-G/C, 402-G/A, 4527-A/T, 4541-G/A, and 4653-A/T. One intronic variant, 412-C/T, was associated with decreased blood glucose levels (frequency = 72%, beta = -14.52, p = 0.02).Three of the associations were not affected after adjusting for LPA KIV-2 CN: 412-C/T (beta = -14.2, p = 0.03), 166-G/A (OR = 1.41, p = 0.05), and 387-G/C (OR = 1.40, p = 0.05). KIV CN itself was significantly associated with 314 variants and was negatively correlated with plasma total cholesterol levels. Conclusions: In three ancestry groups, we identify novel rare and common LPA KIV-2 region variants. We report new associations of variants with HTN and Glucose levels. These results underscore the genetic complexity of the LPA KIV-2 region in influencing cardiovascular and metabolic health, suggesting potential genetic regulation of pathways that can be studied for research and therapeutic interventions.
39040175	34	37	LPA	Gene	4018
39040175	99	105	apo(a)	Gene	4018
39040175	119	126	glucose	Chemical	MESH:D005947
39040175	132	144	hypertension	Disease	MESH:D006973
39040175	163	168	Lp(a)	Chemical	MESH:D010649
39040175	190	228	atherosclerotic cardiovascular disease	Disease	MESH:D050197
39040175	262	265	LPA	Gene	4018
39040175	273	278	Lp(a)	Chemical	MESH:D010649
39040175	319	322	LPA	Gene	4018
39040175	431	436	Lp(a)	Chemical	MESH:D010649
39040175	451	454	CVD	Disease	
39040175	1113	1126	heart disease	Disease	MESH:D006331
39040175	1128	1140	hypertension	Disease	MESH:D006973
39040175	1142	1145	HTN	Disease	MESH:D006973
39040175	1148	1154	stroke	Disease	MESH:D020521
39040175	1156	1161	lipid	Chemical	MESH:D008055
39040175	1195	1214	Alzheimer's disease	Disease	MESH:D000544
39040175	1216	1218	AD	Disease	MESH:D000544
39040175	1540	1543	HTN	Disease	MESH:D006973
39040175	1633	1640	727-T/C	DNAMutation	tmVar:c|SUB|T|727|C;HGVS:c.727T>C;VariantGroup:5;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1686	1693	723-A/G	DNAMutation	tmVar:c|SUB|A|723|G;HGVS:c.723A>G;VariantGroup:2;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1796	1799	HTN	Disease	MESH:D006973
39040175	1805	1808	G/A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:1;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1810	1817	387-G/C	DNAMutation	tmVar:c|SUB|G|387|C;HGVS:c.387G>C;VariantGroup:6;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1819	1826	402-G/A	DNAMutation	tmVar:c|SUB|G|402|A;HGVS:c.402G>A;VariantGroup:0;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1828	1836	4527-A/T	DNAMutation	tmVar:g|SUB|A|4527|T;HGVS:g.4527A>T;VariantGroup:3;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1838	1846	4541-G/A	DNAMutation	tmVar:g|SUB|G|4541|A;HGVS:g.4541G>A;VariantGroup:8;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1852	1860	4653-A/T	DNAMutation	tmVar:g|SUB|A|4653|T;HGVS:g.4653A>T;VariantGroup:10;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1884	1891	412-C/T	DNAMutation	tmVar:c|SUB|C|412|T;HGVS:c.412C>T;VariantGroup:4;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	1923	1936	blood glucose	Chemical	MESH:D001786
39040175	2069	2072	C/T	DNAMutation	tmVar:c|SUB|C||T;VariantGroup:7;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	2103	2106	G/A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:1;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	2138	2141	G/C	DNAMutation	tmVar:c|SUB|G||C;VariantGroup:9;CorrespondingGene:4018;CorrespondingSpecies:9606
39040175	2274	2285	cholesterol	Chemical	MESH:D002784
39040175	2438	2441	HTN	Disease	MESH:D006973
39040175	2446	2453	Glucose	Chemical	MESH:D005947
39040175	Positive_Correlation	HGVS:g.4653A>T;CorrespondingGene:4018	MESH:D006973
39040175	Positive_Correlation	HGVS:c.387G>C;CorrespondingGene:4018	MESH:D006973
39040175	Positive_Correlation	HGVS:c.727T>C;CorrespondingGene:4018	MESH:D006973
39040175	Association	MESH:D001786	MESH:D002784
39040175	Association	MESH:D001786	HGVS:g.4527A>T;CorrespondingGene:4018
39040175	Association	MESH:D010649	4018
39040175	Positive_Correlation	CorrespondingGene:4018;CorrespondingSpecies:9606;VariantGroup:7;tmVar:c	MESH:D006973
39040175	Association	MESH:D006973	4018
39040175	Association	MESH:D001786	4018
39040175	Positive_Correlation	HGVS:g.4541G>A;CorrespondingGene:4018	MESH:D006973
39040175	Positive_Correlation	HGVS:c.402G>A;CorrespondingGene:4018	MESH:D006973
39040175	Positive_Correlation	HGVS:c.412C>T;CorrespondingGene:4018	MESH:D006973
39040175	Association	MESH:D002784	HGVS:c.412C>T;CorrespondingGene:4018
39040175	Association	MESH:D002784	CorrespondingGene:4018;CorrespondingSpecies:9606;VariantGroup:7;tmVar:c
39040175	Positive_Correlation	HGVS:g.4527A>T;CorrespondingGene:4018	MESH:D006973
39040175	Positive_Correlation	CorrespondingGene:4018;CorrespondingSpecies:9606;VariantGroup:1;tmVar:c	MESH:D006973
39040175	Association	MESH:D001786	CorrespondingGene:4018;CorrespondingSpecies:9606;VariantGroup:9;tmVar:c
39040175	Association	MESH:D050197	4018
39040175	Positive_Correlation	MESH:D010649	MESH:D050197
39040175	Positive_Correlation	HGVS:c.723A>G;CorrespondingGene:4018	MESH:D006973
39040175	Positive_Correlation	CorrespondingGene:4018;CorrespondingSpecies:9606;VariantGroup:9;tmVar:c	MESH:D006973
39040175	Association	MESH:D001786	CorrespondingGene:4018;CorrespondingSpecies:9606;VariantGroup:7;tmVar:c
39040175	Association	MESH:D005947	4018
39040175	Association	MESH:D000544	4018
39040175	Association	MESH:D006331	4018
39040175	Association	MESH:D002784	CorrespondingGene:4018;CorrespondingSpecies:9606;VariantGroup:9;tmVar:c

